2021
Assessing the Toxicity of 17 alpha-Ethinylestradiol in Rainbow Trout Using a 4-Day Transcriptomics Benchmark Dose (BMD) Embryo Assay
ALCARAZ, Alper James G., Kamil MIKULÁŠEK, David POTĚŠIL, Bradley PARK, Karman SHEKH et. al.Základní údaje
Originální název
Assessing the Toxicity of 17 alpha-Ethinylestradiol in Rainbow Trout Using a 4-Day Transcriptomics Benchmark Dose (BMD) Embryo Assay
Autoři
ALCARAZ, Alper James G. (124 Kanada), Kamil MIKULÁŠEK (203 Česká republika, domácí), David POTĚŠIL (203 Česká republika, domácí), Bradley PARK (124 Kanada), Karman SHEKH (124 Kanada), Jessica EWALD (124 Kanada), Connor BURBRIDGE (124 Kanada), Zbyněk ZDRÁHAL (203 Česká republika, garant, domácí), David SCHNEIDER (124 Kanada), Jianguo XIA (124 Kanada), Doug CRUMP (124 Kanada), Nilardi BASU (124 Kanada) a Markus HECKER
Vydání
Environmental Science and Technology, American Chemical Society, 2021, 0013-936X
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10511 Environmental sciences
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 11.357
Kód RIV
RIV/00216224:14740/21:00123877
Organizační jednotka
Středoevropský technologický institut
UT WoS
000683363600040
Klíčová slova anglicky
estrogen; risk assessment; transcriptomic benchmark dose (geneBMD); endocrine disruption; alternative toxicity testing
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 2. 11. 2024 20:44, Ing. Martina Blahová
Anotace
V originále
There is an urgent demand for more efficient and ethical approaches in ecological risk assessment. Using 17α-ethinylestradiol (EE2) as a model compound, this study established an embryo benchmark dose (BMD) assay for rainbow trout (RBT; Oncorhynchus mykiss) to derive transcriptomic points-of-departure (tPODs) as an alternative to live-animal tests. Embryos were exposed to graded concentrations of EE2 (measured: 0, 1.13, 1.57, 6.22, 16.3, 55.1, and 169 ng/L) from hatch to 4 and up to 60 days post-hatch (dph) to assess molecular and apical responses, respectively. Whole proteome analyses of alevins did not show clear estrogenic effects. In contrast, transcriptomics revealed responses that were in agreement with apical effects, including excessive accumulation of intravascular and hepatic proteinaceous fluid and significant increases in mortality at 55.1 and 169 ng/L EE2 at later time points. Transcriptomic BMD analysis estimated the median of the 20th lowest geneBMD to be 0.18 ng/L, the most sensitive tPOD. Other estimates (0.78, 3.64, and 1.63 ng/L for the 10th percentile geneBMD, first peak geneBMD distribution, and median geneBMD of the most sensitive over-represented pathway, respectively) were within the same order of magnitude as empirically derived apical PODs for EE2 in the literature. This 4-day alternative RBT embryonic assay was effective in deriving tPODs that are protective of chronic effects of EE2.
Návaznosti
LM2018140, projekt VaV |
| ||
LQ1601, projekt VaV |
| ||
90127, velká výzkumná infrastruktura |
|